- Home
- CLLS vs FCRS Comparison
CLLS vs FCRS Comparison
Compare CLLS & FCRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$1.43
Company Overview
Basic Information| Metric | CLLS | FCRS |
|---|---|---|
| Founded | 1999 | 2025 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 394.4M | 368.4M |
| IPO Year | 2014 | 2025 |
Fundamental Metrics
Financial Performance| Metric | CLLS | FCRS |
|---|---|---|
| Price | $1.43 | $10.24 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $5.33 | N/A |
| AVG Volume (30 Days) | ★ 171.9K | 115.2K |
| Earning Date | 11-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.11 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $10.70 | N/A |
| P/E Ratio | ★ N/A | $93.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.25 | $10.02 |
| 52 Week High | $5.48 | $10.92 |
Technical Indicators
Market Signals| Indicator | CLLS | FCRS |
|---|---|---|
| Relative Strength Index (RSI) | 26.03 | 54.34 |
| Support Level | $1.31 | $10.20 |
| Resistance Level | $3.47 | $10.29 |
| Average True Range (ATR) | 0.14 | 0.02 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 17.81 | 60.00 |
Price Performance
Historical Comparison CLLS
FCRS
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About FCRS FutureCrest Acquisition Corp. Class A Ordinary Shares
FutureCrest Acquisition Corp is a blank check company.